Lv51
1340 积分 2026-01-10 加入
Effect of adjuvant EGFR-TKI therapy on the prognosis of pathological stage I invasive lung adenocarcinoma with sensitive EGFR mutations
2个月前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
3个月前
已完结
Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer
4个月前
已完结
Clinical overview of trophoblast surface antigen 2 Antibody-Drug conjugates in Non–Small cell lung cancer
4个月前
已完结
Management of adverse events associated with TROP2-targeted antibody-drug conjugates in cancer patients
4个月前
已完结
Trop2 immunoPET/CT in clinical practice: facts and challenges
4个月前
已完结
TROP2-Targeted Therapeutics in Development to Treat Gastrointestinal Tumors
5个月前
已完结
Molecular Advances in Gastrointestinal Pathology
5个月前
已关闭
Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trial
5个月前
已完结
Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transition
6个月前
已完结